Herceptin breast cancer drug, molecular model. Herceptin (Trastuzumab) is a monoclonal antibody that binds to the HER2 receptor (human epidermal growt

---

Herceptin breast cancer drug, molecular model. Herceptin (Trastuzumab) is a monoclonal antibody that binds to the HER2 receptor (human epidermal growth factor receptor 2) on breast cancer cells, causing them to die during their reproductive cycle. Around a fifth of breast cancers are made up of cells that over-express this receptor, making them viable for Herceptin treatment. In this model the molecule's shape (secondary structure) is seen, comprising alpha helices (coils), beta sheets (arrows) and linking regions (lines).

---

Size: 4835px × 3626px
Photo credit: © EQUINOX GRAPHICS/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: 2, alpha, antibody, artwork, beta, biochemical, biochemistry, biological, biology, breast, cancer, chemical, chemistry, chemotherapy, compound, compounds, drug, epidermal, factor, growth, helices, helix, her2, herceptin, human, illustration, immunology, medical, medicine, model, molecular, molecule, molecules, monoclonal, oncology, person, pharmacological, pharmacology, protein, proteins, receptor, secondary, sheet, sheets, structure, therapy, trastuzumab, treatment, tumour